The efficacy of modified bloodless del Nido cardioplegia in isolated aortic valve replacement. [PDF]
This study aimed to evaluate the safety and efficacy of a modified, bloodless Del Nido (DN) cardioplegia solution in patients undergoing isolated aortic valve replacement (AVR).
Bongyeon Sohn +3 more
doaj +3 more sources
Single-dose modified bloodless del Nido cardioplegia for minimally invasive cardiac surgery [PDF]
BackgroundRecent studies demonstrated satisfactory results of del Nido cardioplegia in minimally invasive cardiac surgery (MICS). We aimed to evaluate the efficacy of our modified “bloodless” del Nido cardioplegia in MICS compared to the histidine ...
Heemoon Lee, Jihoon Kim, Jae Suk Yoo
doaj +4 more sources
Cerebral Inflammation in an Animal Ischemia–Reperfusion Model Comparing Histidine-Tryptophan-α-Ketoglutarate and Del Nido Cardioplegia [PDF]
Brain injury and cerebral inflammation are frequent complications following cardiopulmonary bypass (CPB) resulting in neurocognitive dysfunction, encephalopathy, or stroke.
Kristin Klaeske +8 more
doaj +3 more sources
Modified Del Nido Cardioplegia with a 1:4 Crystalloid-to-Blood Ratio Versus Blood-Based St. Thomas Cardioplegia in Isolated Aortic Valve Replacement [PDF]
The aim of this study was to retrospectively compare modified Del Nido and blood-based St. Thomas cardioplegia in adult patients undergoing isolated aortic valve replacement (AVR).
Peter Jakub +7 more
doaj +2 more sources
Evaluating the need for magnesium administration following cardioplegic arrest with del Nido cardioplegia solution [PDF]
Background: del Nido cardioplegia (dNC) solution is widely used in pediatric and congenital cardiac surgery. In 2014, Cincinnati Children’s Hospital Medical Center (CCHMC) changed from Mee cardioplegic solution to dNC. Since Mee solution does not contain
Whittaker Striker Carrie +1 more
doaj +2 more sources
Modified Del Nido Versus Custodiol® Cardioplegia for Myocardial Protection in Adult Patients Undergoing Cardiac Surgery; A Prospective Randomized Double-Blinded Clinical Trial [PDF]
Background: Cardioplegia is essential for myocardial protection. Modified Del Nido and Custodiol® cardioplegia have been successfully used; however, a limited number of clinical trials compared both solutions.
Mahdy A. Abdelhady +4 more
doaj +2 more sources
The effect of administration of Del Nido cardioplegia solution containing vitamin C on myocardial protection and clinical outcomes in patients undergoing coronary artery bypass graft surgery [PDF]
Background A main concern during cardiac surgery is the protection of the heart. Myocardial ischemia tends to increase the generation of reactive oxygen species.
Farshad Jalili Shahandashti +8 more
doaj +2 more sources
Comparison of del Nido and blood cardioplegia on metabolic changes and acid–base balance in adult cardiac surgeries under cardiopulmonary bypass [PDF]
Background and Aims: del Nido cardioplegia (DC), initially developed for paediatric cardiac surgery, is increasingly used in adult procedures due to its ability to provide prolonged myocardial protection with a single dose.
Prashanth Chintalapudi +5 more
doaj +2 more sources
Saline-based modified del Nido cardioplegia versus multidose St. Thomas cardioplegia in canine mitral valve repair: A randomized controlled trial. [PDF]
Abstract Objective To compare the utility of a saline‐based modified del Nido (mDN) cardioplegia solution with a conventional institutional technique (multidose St. Thomas blood cardioplegia) for mitral valve repair (MVR) in dogs. Study design Prospective, randomized, open‐label trial.
Kurogochi K +7 more
europepmc +2 more sources
del Nido versus St. Thomas’ blood cardioplegia in the young (DESTINY) trial: protocol for a multicentre randomised controlled trial in children undergoing cardiac surgery [PDF]
Introduction Myocardial protection against ischaemia–reperfusion injury is a key determinant of heart function and outcome following cardiac surgery in children.
Massimo Caputo +15 more
doaj +2 more sources

